Literature DB >> 25287158

Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis.

Yusuke Yamamoto1, Hisashi Ikoma2, Ryo Morimura1, Hirotaka Konishi1, Yasutoshi Murayama1, Shuhei Komatsu1, Atsushi Shiozaki1, Yoshiaki Kuriu1, Takeshi Kubota1, Masayoshi Nakanishi1, Daisuke Ichikawa1, Hitoshi Fujiwara1, Kazuma Okamoto1, Chouhei Sakakura1, Toshiya Ochiai3, Eigo Otsuji1.   

Abstract

BACKGROUND: The term "early recurrence" of pancreatic cancer has not been well-defined in most previous studies.
METHODS: The clinical records of 86 patients who underwent macroscopic curative pancreatectomy for pancreatic cancer between 2000 and 2009 were retrospectively examined. We divided 55 patients who experienced disease recurrence into two groups, the early and late recurrence groups, using the minimum p value approach. The relationships between the interval prior to recurrence and clinical outcomes were investigated.
RESULTS: The cumulative 5-year overall survival rates for all 86 patients were 30.2%. For 55 patients who experienced disease recurrence, the optimal cut-off value for differentiating early (n = 37) and late (n = 18) recurrence based on the overall survival was 12 months (p = 0.0000045). The Cox proportional hazard analysis identified carbohydrate antigen 19-9 > 100 U/ml (p = 0.017) and surgical margin (p = 0.007) as the independent prognostic factors associated with overall survival. Positive surgical margin (p = 0.037) and severe venous invasion (p = 0.005) were identified as independent factors associated with early recurrence.
CONCLUSION: Twelve months after pancreatectomy is the optimal cut-off value for defining early versus late recurrence based on the overall survival. Early recurrence was related to the status of the surgical margin and venous invasion.
Copyright © 2014 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Early recurrence; Late recurrence; Minimum p value approach; Pancreatectomy; Pancreatic cancer; Positive surgical margin

Mesh:

Substances:

Year:  2014        PMID: 25287158     DOI: 10.1016/j.pan.2014.09.006

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  11 in total

1.  Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China.

Authors:  Weikang Liu; Bingjun Tang; Feng Wang; Chang Qu; Hao Hu; Yan Zhuang; Hongqiao Gao; Xuehai Xie; Xiaodong Tian; Yinmo Yang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

2.  Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Vincent P Groot; Georgios Gemenetzis; Alex B Blair; Roberto J Rivero-Soto; Jun Yu; Ammar A Javed; Richard A Burkhart; Inne H M Borel Rinkes; I Quintus Molenaar; John L Cameron; Matthew J Weiss; Christopher L Wolfgang; Jin He
Journal:  Ann Surg       Date:  2018-03-23       Impact factor: 12.969

3.  Upregulated HSPA2 predicts early relapse of pancreatic cancer after surgery.

Authors:  Lu-Lu Zhai; Pei-Pei Qiao; Yue-Shen Sun; Zhi-Gang Tang; Tong-Fa Ju
Journal:  Gland Surg       Date:  2021-07

4.  Predictors of early recurrence following a curative resection in patients with a carcinoma of the ampulla of Vater.

Authors:  Chung Hyeun Ma; Jae Hoon Lee; Ki Byung Song; Dae Wook Hwang; Song Cheol Kim
Journal:  Ann Surg Treat Res       Date:  2020-10-28       Impact factor: 1.859

5.  Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.

Authors:  Lu-Lu Zhai; Yang Wu; Da-Wei Huang; Zhi-Gang Tang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

6.  Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection?

Authors:  Atsushi Oba; Yosuke Inoue; Yoshihiro Ono; Shoichi Irie; Takafumi Sato; Yoshihiro Mise; Hiromichi Ito; Yu Takahashi; Akio Saiura
Journal:  Langenbecks Arch Surg       Date:  2019-11-28       Impact factor: 3.445

7.  Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Vincent P Groot; Georgios Gemenetzis; Alex B Blair; Roberto J Rivero-Soto; Jun Yu; Ammar A Javed; Richard A Burkhart; Inne H M Borel Rinkes; I Quintus Molenaar; John L Cameron; Matthew J Weiss; Christopher L Wolfgang; Jin He
Journal:  Ann Surg       Date:  2019-06       Impact factor: 13.787

8.  Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.

Authors:  Hai-Jie Hu; Yan-Wen Jin; Anuj Shrestha; Wen-Jie Ma; Jun-Ke Wang; Fei Liu; Ya-Yun Zhu; Rong-Xing Zhou; Parbatraj Regmi; Nan-Sheng Cheng; Fu-Yu Li
Journal:  Cancer Med       Date:  2019-03-13       Impact factor: 4.452

9.  Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.

Authors:  Tian-Yu Tang; Xiang Li; Qi Zhang; Cheng-Xiang Guo; Xiao-Zhen Zhang; Meng-Yi Lao; Yi-Nan Shen; Wen-Bo Xiao; Shi-Hong Ying; Ke Sun; Ri-Sheng Yu; Shun-Liang Gao; Ri-Sheng Que; Wei Chen; Da-Bing Huang; Pei-Pei Pang; Xue-Li Bai; Ting-Bo Liang
Journal:  J Magn Reson Imaging       Date:  2019-12-23       Impact factor: 4.813

10.  Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma.

Authors:  Sarang Hong; Ki Byung Song; Dae Wook Hwang; Jae Hoon Lee; Woohyung Lee; Eunsung Jun; Jaewoo Kwon; Yejong Park; Seo Young Park; Naru Kim; Dakyum Shin; Hyeyeon Kim; Minkyu Sung; Yunbeom Ryu; Song Cheol Kim
Journal:  World J Gastrointest Surg       Date:  2021-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.